BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

674 related articles for article (PubMed ID: 31237043)

  • 1. Interobserver agreement in MRI assessment of severity of placenta accreta spectrum disorders.
    Finazzo F; D'antonio F; Masselli G; Forlani F; Palacios-Jaraquemada J; Minneci G; Gambarini S; Timor-Tritsch I; Prefumo F; Buca D; Liberati M; Khalil A; Cali G
    Ultrasound Obstet Gynecol; 2020 Apr; 55(4):467-473. PubMed ID: 31237043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Third-trimester ultrasound for antenatal diagnosis of placenta accreta spectrum in women with placenta previa: results from the ADoPAD study.
    Fratelli N; Prefumo F; Maggi C; Cavalli C; Sciarrone A; Garofalo A; Viora E; Vergani P; Ornaghi S; Betti M; Vaglio Tessitore I; Cavaliere AF; Buongiorno S; Vidiri A; Fabbri E; Ferrazzi E; Maggi V; Cetin I; Frusca T; Ghi T; Kaihura C; Di Pasquo E; Stampalija T; Belcaro C; Quadrifoglio M; Veneziano M; Mecacci F; Simeone S; Locatelli A; Consonni S; Chianchiano N; Labate F; Cromi A; Bertucci E; Facchinetti F; Fichera A; Granata D; D'Antonio F; Foti F; Avagliano L; Bulfamante GP; Calì G;
    Ultrasound Obstet Gynecol; 2022 Sep; 60(3):381-389. PubMed ID: 35247287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective evaluation of impact of post-Cesarean section uterine scarring in perinatal diagnosis of placenta accreta spectrum disorder.
    Hussein AM; Elbarmelgy RA; Elbarmelgy RM; Thabet MM; Jauniaux E
    Ultrasound Obstet Gynecol; 2022 Apr; 59(4):474-482. PubMed ID: 34225385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracervical lakes as sonographic marker of placenta accreta spectrum disorder in patients with placenta previa or low-lying placenta.
    di Pasquo E; Ghi T; Calì G; D'Antonio F; Fratelli N; Forlani F; Prefumo F; Kaihura CT; Volpe N; Dall'Asta A; Frusca T
    Ultrasound Obstet Gynecol; 2020 Apr; 55(4):460-466. PubMed ID: 31503353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal ultrasound staging system for placenta accreta spectrum disorders.
    Cali G; Forlani F; Lees C; Timor-Tritsch I; Palacios-Jaraquemada J; Dall'Asta A; Bhide A; Flacco ME; Manzoli L; Labate F; Perino A; Scambia G; D'Antonio F
    Ultrasound Obstet Gynecol; 2019 Jun; 53(6):752-760. PubMed ID: 30834661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of ultrasound features of placenta accreta spectrum in women at high risk: association with outcome and interobserver concordance.
    Bhide A; Hussein AM; Elbarmelgy RM; Elbarmelgy RA; Thabet MM; Jauniaux E
    Ultrasound Obstet Gynecol; 2023 Jul; 62(1):137-142. PubMed ID: 36882604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of specific MRI features in the evaluation of suspected placental invasion.
    Lax A; Prince MR; Mennitt KW; Schwebach JR; Budorick NE
    Magn Reson Imaging; 2007 Jan; 25(1):87-93. PubMed ID: 17222719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review on near miss cases of placenta accreta spectrum disorders: correlation with invasion topography, prenatal imaging, and surgical outcome.
    Palacios-Jaraquemada JM; D'Antonio F; Buca D; Fiorillo A; Larraza P
    J Matern Fetal Neonatal Med; 2020 Oct; 33(19):3377-3384. PubMed ID: 30700221
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of Ultrasound and MRI in Diagnosis of Severe Placenta Accreta Spectrum Disorder: An Intraindividual Assessment With Emphasis on Placental Bulge.
    Thiravit S; Ma K; Goldman I; Chanprapaph P; Jha P; Hippe DS; Dighe M
    AJR Am J Roentgenol; 2021 Dec; 217(6):1377-1388. PubMed ID: 34037411
    [No Abstract]   [Full Text] [Related]  

  • 10. Value of first-trimester ultrasound in prediction of third-trimester sonographic stage of placenta accreta spectrum disorder and surgical outcome.
    Calí G; Timor-Tritsch IE; Forlani F; Palacios-Jaraquemada J; Monteagudo A; Kaelin Agten A; Flacco ME; Khalil A; Buca D; Manzoli L; Liberati M; D'Antonio F
    Ultrasound Obstet Gynecol; 2020 Apr; 55(4):450-459. PubMed ID: 31788885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy and Interobserver Reliability of Magnetic Resonance Imaging for Placenta Accreta Spectrum Disorders.
    Einerson BD; Rodriguez CE; Silver RM; Donnelly MA; Kennedy AM; Woodward PJ
    Am J Perinatol; 2021 Jul; 38(9):960-967. PubMed ID: 31986538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of ultrasound in detecting the depth of invasion in women at risk of abnormally invasive placenta: A prospective longitudinal study.
    Cali G; Forlani F; Timor-Trisch I; Palacios-Jaraquemada J; Foti F; Minneci G; Flacco ME; Manzoli L; Familiari A; Pagani G; Scambia G; D'Antonio F
    Acta Obstet Gynecol Scand; 2018 Oct; 97(10):1219-1227. PubMed ID: 29797715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antenatal diagnosis of placenta accreta spectrum (PAS) disorders.
    Yu FNY; Leung KY
    Best Pract Res Clin Obstet Gynaecol; 2021 Apr; 72():13-24. PubMed ID: 32747328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified Delphi study of ultrasound signs associated with placenta accreta spectrum.
    Jauniaux E; D'Antonio F; Bhide A; Prefumo F; Silver RM; Hussein AM; Shainker SA; Chantraine F; Alfirevic Z;
    Ultrasound Obstet Gynecol; 2023 Apr; 61(4):518-525. PubMed ID: 36609827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors, histopathology and diagnostic accuracy in posterior placenta accreta spectrum disorders: systematic review and meta-analysis.
    Tinari S; Buca D; Cali G; Timor-Tritsch I; Palacios-Jaraquemada J; Rizzo G; Lucidi A; Di Mascio D; Liberati M; D'Antonio F
    Ultrasound Obstet Gynecol; 2021 Jun; 57(6):903-909. PubMed ID: 32840934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging.
    Jauniaux E; Collins S; Burton GJ
    Am J Obstet Gynecol; 2018 Jan; 218(1):75-87. PubMed ID: 28599899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI prognosticators for adverse maternal and neonatal clinical outcome in patients at high risk for placenta accreta spectrum (PAS) disorders.
    Bourgioti C; Zafeiropoulou K; Fotopoulos S; Nikolaidou ME; Theodora M; Daskalakis G; Tzavara C; Chatoupis K; Panourgias E; Antoniou A; Konstantinidou A; Moulopoulos LA
    J Magn Reson Imaging; 2019 Aug; 50(2):602-618. PubMed ID: 30578609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new methodologic approach for clinico-pathologic correlations in invasive placenta previa accreta.
    Jauniaux E; Hussein AM; Zosmer N; Elbarmelgy RM; Elbarmelgy RA; Shaikh H; Burton GJ
    Am J Obstet Gynecol; 2020 Apr; 222(4):379.e1-379.e11. PubMed ID: 31730756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of MRI-based scoring models for predicting placental invasiveness in high-risk women for placenta accreta spectrum.
    Liu Q; Zhou W; Yan Z; Li D; Lou T; Yuan Y; Rong P; Feng Z
    Eur Radiol; 2024 Feb; 34(2):957-969. PubMed ID: 37589907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of first-trimester ultrasound in detecting abnormally invasive placenta in high-risk women with placenta previa.
    Cali G; Forlani F; Foti F; Minneci G; Manzoli L; Flacco ME; Buca D; Liberati M; Scambia G; D'Antonio F
    Ultrasound Obstet Gynecol; 2018 Aug; 52(2):258-264. PubMed ID: 29532529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.